SS-31 Peptide: Repairing Cardiolipin to Restore ATP + Mitochondrial Energy

SS-31 isn't necessarily directly influencing your body's metabolism or ability to recover. It works several steps upstream of both of those things, and the only way the rest of it makes sense is if you follow the whole chain from food to the moment a cell actually spends energy.

Your body's primary, we'll say, currency for energy is ATP. And ATP is produced inside of the mitochondria, more specifically inside of what's called your electron transport chain.

Here is the full pathway before we zoom in anywhere.

You eat, and the carbohydrate and fat and protein get broken down into small carbon molecules that feed into a loop inside the mitochondria called the Krebs cycle, and the entire purpose of that loop is to strip electrons off those carbon molecules and load them onto two carrier molecules called NADH and FADH2.

Those carriers walk the electrons over to the inner membrane of the mitochondria and hand them off to a series of large protein complexes sitting in that membrane, and those complexes pass the electrons down a line, one to the next, like a bucket brigade.

Every handoff releases a small amount of energy, and the complexes use that energy to pump hydrogen ions from one side of the membrane to the other, which builds up pressure on one side the same way water builds up behind a dam.

Then that pressure is released through a single spinning protein called ATP synthase, and the spinning is what physically welds a phosphate onto ADP to make ATP. Electrons in, proton pressure built, pressure released, ATP out.

At the end of the line the electrons get handed to oxygen, which is the actual reason you breathe. Not for the oxygen itself, but because oxygen is the last thing in the chain willing to accept an electron so the whole line can keep moving.

So every complex in that chain has to be physically positioned right next to the next one, in the right orientation, at the right distance, or the electron handoff slows down or misses entirely, and almost nobody talks about the reason that positioning holds: that electron transport chain lives inside a fat membrane inside your mitochondria called cardiolipin.

Cardiolipin is a phospholipid, meaning a fat molecule that builds membranes, but it is built differently than every other fat in your body. Normal membrane phospholipids have two fatty acid tails, while cardiolipin has four, and that difference in tail count is what sets the whole thing apart.

That fourth tail changes cardiolipin's shape, turning it from a cylinder that would stack flat into a sheet into something closer to a cone, and cones refuse to stack flat, which forces the membrane itself to bend.

That bending is the entire point, because the inner mitochondrial membrane is folded into deep pleats called cristae rather than shaped like a smooth balloon, and the folds are what create enough surface area to hold thousands of copies of the electron transport chain inside a space you need a microscope to see.

Ikon and Ryan laid this out clearly in their 2017 review in Biochimica et Biophysica Acta, that cardiolipin makes up roughly a fifth of the phospholipid in that inner membrane and is essentially found nowhere else in the cell, and that the curvature it creates is what organizes cristae in the first place.

So the cardiolipin's job is to basically hold your electron transport chain in the right shape while it's doing its job.

It manages that in two ways, first by bending the membrane so the folds form, and second by physically binding to the individual complexes and gluing them into clusters called supercomplexes, where complex I sits locked against complex III sits locked against complex IV, so an electron can move between them without ever floating loose in the membrane.

Vercellino and Sazanov, writing in Nature Reviews Molecular Cell Biology in 2022, describe these supercomplexes as structurally dependent on cardiolipin molecules wedged into the seams between complexes, filling the gaps like mortar between bricks.

When the mortar is there, electrons move fast and almost none of them escape. When it is missing, the bricks drift apart, the handoffs get sloppy, and electrons start leaking out of the chain early.

A leaked electron does not simply vanish, it hits an oxygen molecule partway down the line and creates a reactive oxygen species, a free radical, which then goes looking for something to react with.

And the closest thing for it to react with is the cardiolipin itself, sitting inches away in molecular terms, packed with the polyunsaturated fatty acid tails that free radicals attack most easily. In heart muscle, the dominant form of cardiolipin carries four linoleic acid tails, and linoleic acid is exactly the kind of fat that oxidizes fastest.

So damaged cardiolipin causes electron leak, and electron leak causes more damaged cardiolipin, and the loop feeds itself.

There is a second layer to that loop. Cytochrome c, the small protein that shuttles electrons between complex III and complex IV, is normally held to the membrane by cardiolipin, and when the cardiolipin around it becomes oxidized, that binding changes cytochrome c into an enzyme that oxidizes cardiolipin even faster.

The molecule responsible for carrying electrons turns on the membrane holding it in place. That is the point where a slow decline becomes a spiral.

And as you age, metabolic stress, poor diet, insulin resistance, not sleeping, not taking care of yourself, drug abuse, alcohol, just life basically causes, we'll say damage over time to this fat membrane.

None of those hit cardiolipin in some abstract way. Insulin resistance means more substrate arriving at the mitochondria than the chain can process, which backs up electron flow and increases leak. Alcohol metabolism dumps a large load of NADH into the same chain. Poor sleep raises the amount of time you spend in a state of elevated oxidative load without the repair window to clear it.

Su and colleagues, in a 2023 paper in Autophagy on kidney injury, described what the cell does next, which is that oxidized cardiolipin gets flipped from the inner membrane to the outer surface of the mitochondria where it acts as a flag, and that flag tells the cell to wrap that mitochondria up and digest it.

That is a reasonable system when a few mitochondria are damaged. It becomes a problem when a large fraction of them are flagged at the same time, because you lose capacity faster than you can rebuild it.

And when cardiolipin production is cut off entirely, the collapse is fast and it is measurable. Brothwell and colleagues published work in 2025 showing that removing the enzyme that synthesizes cardiolipin destabilized the electron transport chain and drove the liver into steatohepatitis, meaning fat accumulation plus inflammation, from a lipid change alone.

That is the version of this you can see in a lab. The version most people are living is slower and does not have a diagnosis attached to it.

SS-31's job is specifically to go in and repair the cardiolipin.

Mechanically, SS-31 is a four amino acid peptide with an alternating pattern of positively charged and aromatic residues, and that pattern is what lets it do something unusual, which is concentrate itself in the inner mitochondrial membrane at somewhere between one thousand and five thousand times the concentration found in the rest of the cell, without needing the membrane voltage to pull it in and without collapsing that voltage once it arrives.

Once there, it binds directly to cardiolipin, with the positive charges holding onto the negatively charged head of the cardiolipin molecule while the aromatic ring tucks into the fatty layer, so the peptide sits at the interface rather than pushing through the membrane.

What that binding does is restore the packing. The complexes get pulled back into their supercomplex arrangement, the cristae curvature tightens back up, the electron handoffs shorten, and the leak rate drops.

It also blocks the cytochrome c peroxidase reaction, which is the part that breaks the self-feeding loop. Less oxidation of cardiolipin means less cytochrome c conversion means less oxidation still.

The word repair is doing some work there and it is worth being precise about it, because SS-31 does not chemically rebuild an oxidized fatty acid tail and it does not manufacture new cardiolipin. It restores the structural function of the membrane that the cardiolipin is supposed to be providing, which is why the effect shows up as improved ATP output rather than as a change on a lipid panel.

This matters at a level you can actually feel.

ATP runs every process in your body, brain function, digestion, heartbeat, and everything that's happening is being driven by the production of ATP, so when that output drops, everything downstream slows with it.

Your body turns over something in the range of your own body weight in ATP every day, because you only carry a few seconds worth at any moment and the rest is recycled continuously. Your brain alone runs on roughly a fifth of your total energy budget while weighing about two percent of you.

So a ten or fifteen percent reduction in mitochondrial output does not show up as one broken system. It shows up as everything getting a little worse at once, which is why it gets dismissed.

Recovery takes an extra day, and focus drops off after ninety minutes instead of three hours. Digestion gets sluggish because the intestinal lining is one of the most ATP hungry tissues you have. Sleep quality degrades because clearing metabolic waste from the brain is itself an energy dependent process.

DiMauro described this pattern in inherited mitochondrial disease decades ago, where the tissues that fail first are the ones with the highest energy demand, which is muscle, brain, heart, eye. Fernandez-Vizarra and Zeviani made the same structural point in their 2021 review, that defects in oxidative phosphorylation produce symptoms in whatever tissue crosses its energy threshold first.

The genetic version is severe and rare, while the acquired version, the one that comes from twenty years of poor sleep and metabolic stress, is common enough that it sits below the threshold of any test your doctor is going to run.

What we're doing is we're basically repairing your cells' ability to just be stable and produce that energy effectively the way that it's supposed to.

On the evidence, the honest position is that the mechanism is well characterized and the clinical results are uneven. The cardiolipin binding, the supercomplex stabilization, the reduction in electron leak, all of that is documented in cell and animal work. The large human trial in primary mitochondrial myopathy did not hit its primary endpoint, which was a six minute walk test, and that matters because it tells you this is not something that overrides a genetically broken complex.

What it does is restore the environment those complexes operate in, which is a different problem, and it is the more common one.

Practically, the simplest lever is the one that reduces the rate of damage, because SS-31 stabilizes the cardiolipin you have and does nothing to make more of it. Cardiolipin synthesis is driven by the same signals as mitochondrial biogenesis, which means low intensity aerobic work done consistently, adequate sleep, and not spending most of your day with more substrate in circulation than your mitochondria can burn.

Pairing it with anything that builds new mitochondrial mass makes more sense than running it alone, because one is restoring the machinery and the other is adding to it, and they are not competing for the same job.

There is a way of thinking about tiredness where it is a signal you need more input, more caffeine, more stimulus, more pressure. The cardiolipin picture says something different, which is that the energy was never being generated by pushing harder in the first place, it was being conducted through a folded sheet of fat that has to hold a specific shape for the electrons to make it across.

Flatten the folds and the electrons still move, just slower and messier, and every system downstream reads that as a smaller budget. Your fatigue is a geometry problem two layers below the place you feel it.

References:

Cai X, Ng CP, Jones O et al.. Lactate activates the mitochondrial electron transport chain independently of its metabolism. Mol Cell. 2023. https://pubmed.ncbi.nlm.nih.gov/37879334/

Vercellino I, Sazanov LA. The assembly, regulation and function of the mitochondrial respiratory chain. Nat Rev Mol Cell Biol. 2022. https://pubmed.ncbi.nlm.nih.gov/34621061/

Fernandez-Vizarra E, Zeviani M. Mitochondrial disorders of the OXPHOS system. FEBS Lett. 2021. https://pubmed.ncbi.nlm.nih.gov/33159691/

Su L, Zhang J, Gomez H et al.. Mitochondria ROS and mitophagy in acute kidney injury. Autophagy. 2023. https://pubmed.ncbi.nlm.nih.gov/35678504/

DiMauro S. Mitochondrial myopathies. Curr Opin Rheumatol. 2006. https://pubmed.ncbi.nlm.nih.gov/17053512/

Brothwell MJ, Cao G, Maschek JA et al.. Cardiolipin deficiency disrupts electron transport chain to drive steatohepatitis. bioRxiv. 2025. https://pubmed.ncbi.nlm.nih.gov/39416056/

Ikon N, Ryan RO. Cardiolipin and mitochondrial cristae organization. Biochim Biophys Acta Biomembr. 2017. https://pubmed.ncbi.nlm.nih.gov/28336315/

Yu J, Luo Y, Lin J et al.. Mitochondrial cristae remodeling: Mechanisms, functions, and pathology. Cell Insight. 2025. https://pubmed.ncbi.nlm.nih.gov/41244322/